2021
DOI: 10.1007/s12602-021-09783-7
|View full text |Cite
|
Sign up to set email alerts
|

A New Approach to Harness Probiotics Against Common Bacterial Skin Pathogens: Towards Living Antimicrobials

Abstract: In this study, the potential of certain lactic acid bacteria—classified as probiotics and known to be antimicrobially active against pathogens or food-poisoning microorganisms—was evaluated with respect to their activity against bacterial skin pathogens. The aim of the study was to develop a plaster/bandage for the application of inhibitory substances produced by these probiotics when applied to diseased skin. For this purpose, two Streptococcus salivarius strains and one Lactobacillus plantarum were tested fo… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

0
11
0
1

Year Published

2021
2021
2024
2024

Publication Types

Select...
6
2
1

Relationship

0
9

Authors

Journals

citations
Cited by 17 publications
(12 citation statements)
references
References 72 publications
0
11
0
1
Order By: Relevance
“…[135]. as well as two S. salivarius strains and one L. plantarum strain, were also reported to show antimicrobal activity in in vitro studies against C. acnes and other pathogens [136].…”
Section: Acnementioning
confidence: 99%
“…[135]. as well as two S. salivarius strains and one L. plantarum strain, were also reported to show antimicrobal activity in in vitro studies against C. acnes and other pathogens [136].…”
Section: Acnementioning
confidence: 99%
“…We determined the antagonistic activity between oral probiotics and pathogens using line tests (a conventional antagonism test) as previously described, with minor modifications [46]. In summary, 20 µL S. mutans culture diluted to 10 6 CFU/mL was first dropped onto agar mixed with equal amounts of BHI and MRS or BHI alone and allowed to flow vertically.…”
Section: Evaluation Of Oral Probiotic Antagonism Against Oral Pathogensmentioning
confidence: 99%
“…The report of Benítez-Chao et al (2021) gave emphasis on the necessity to increase in vivo testing of bacteriocins and advance the in vivo models that both evaluate the efficacy of bacteriocins as antimicrobial agents and introspect probable toxicity and side effects, which are crucial factors to define their achievement as prospective therapeutic agents in the fight against infections triggered by multidrug-resistant microorganism. In a recent report by Khalfallah et al (2021), antimicrobials from two Streptococcus salivarius strains and one Lactobacillus plantarum were used to develop a plaster/bandage for the application to diseased skin. The anti-cancer activity of bacteriocin to other types of organs also reported.…”
Section: Bacterial Therapy Of Cancer-a Newer Approachmentioning
confidence: 99%